Switch to:
More From Other Websites
Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA Sep 19 2014
Insider Buys at Halozyme Look to Improve Stock Outlook Sep 18 2014
SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For... Sep 18 2014
Halozyme Therapeutics (HALO) Jumps: Stock Up 9.3% Sep 18 2014
FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency Sep 12 2014
Why You Shouldn't Bet Against Halozyme Therapeutics (HALO) Stock Sep 08 2014
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation Sep 03 2014
Halozyme Gains on Narrower-than-Expected Loss, Revenues Up Aug 14 2014
HALOZYME THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 11 2014
Halozyme Reports Second Quarter 2014 Financial Results Aug 11 2014
Q2 2014 Halozyme Therapeutics, Inc. Earnings Release - After Market Close Aug 11 2014
Halozyme to Host second Quarter 2014 Financial Results Conference Call Aug 04 2014
Trade-Ideas: Halozyme Therapeutics (HALO) Is Today's "Perilous Reversal" Stock Aug 01 2014
Halozyme Therapeutics Receives Favorable FDA Decision Jul 31 2014
FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter’s HyQvia for Primary... Jul 31 2014
FDA panel: Benefit of Baxter's immune therapy outweighs risk Jul 31 2014
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer Jul 22 2014
Trade-Ideas: Halozyme Therapeutics (HALO) Is Today's "Perilous Reversal" Stock Jul 21 2014
BUZZ-U.S. Stocks on the Move-Isle of Capri, Intercloud, Rent-A-Center Jul 11 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial